Citations

Mayo Clinic

Showing 10 of 108572 citations.

Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant
Vincenti, Flavio , Bestard, Oriol , Brar, Amarpali, Cruzado, Josep M. , Serón, Daniel , Gaber, A. Osama , Ali, Nicole , Tambur, Anat R. , Lee, Helen , Abbadessa, Giovanni , Paul, Jo-Anne, Dudek, Markus , Siegel, Ruby J. , Torija, Alba , Sémiond, Dorothée, Lépine, Lucie, Ternès, Nils, Stegall, Mark, Gaber, Ahmed Osama , Bestard, Oriol , Montgomery, Robert A. , Stegall, Mark D.

Journal of the American Society of Nephrology | December 26, 2023 | Volume: 35 | Issue: 3 | Pages: 347-360

10.1681/asn.0000000000000287 | PMID 38147137 Get It

Significance Statement There is no standardized desensitization regimen for kidney transplant candidates. CD38, expressed by plasma cells, could be targeted for desensitization to deplete plasma cells producing alloantibodies and donor-specific antibodies. Few studies and case reports are available regarding the use of CD38 antibodies for desensitization in patients awaiting kidney transplant. This study shows that isatuximab, a CD38-targeting therapy, was well tolerated in kidney transplant candidates, with a durable decrease in anti-HLA antibodies and partial desensitization activity. The short treatment period and long follow-up of this study allowed for the understanding of the mechanism and timing for any antibody rebound. Isatuximab could be further investigated as an option for adjunct therapy to existing desensitization for patients on the kidney transplant waitlist. Background Patients with calculated panel reactive antibody (cPRA) ≥80.00%, particularly those with cPRA ≥99.90%, are considered highly sensitized and underserved by the Kidney Allocation System. Desensitization removes circulating reactive antibodies and/or suppresses antibody production to increase the chances of a negative crossmatch. CD38 is expressed highly on plasma cells, thus is a potential target for desensitization. Methods This was an open-label single-arm phase 1/2 study investigating the safety, pharmacokinetics, and preliminary efficacy of isatuximab in patients awaiting kidney transplantation. There were two cohorts, cohorts A and B, which enrolled cPRA ≥99.90% and 80.00% to <99.90%, respectively. Results Twenty-three patients (12 cohort A, 11 cohort B) received isatuximab 10 mg/kg weekly for 4 weeks then every 2 weeks for 8 weeks. Isatuximab was well tolerated with pharmacokinetic and pharmacodynamic profiles that indicated similar exposure to multiple myeloma trials. It resulted in decreases in CD38 + plasmablasts, plasma cells, and NK cells and significant reductions in HLA-specific IgG-producing memory B cells. Overall response rate, on the basis of a predefined composite desensitization end point, was 83.3% and 81.8% in cohorts A and B. Most responders had decreases in anti-HLA antibodies that were maintained for 26 weeks after the last dose. Overall, cPRA values were minimally affected, however, with only 9/23 patients (39%) having cPRA decreases to target levels. By study cutoff (median follow-up of 68 weeks), six patients received transplant offers, of which four were accepted. Conclusions In this open-label trial, isatuximab was well tolerated and resulted in a durable decrease in anti-HLA antibodies with partial desensitization activity. Clinical Trial registration number NCT04294459.
Direct pseudomeningocele contrast injection for spinal CSF leak localization
Mark, Ian T. , Madhavan, Ajay A. , DeLone, David R. , Oien, Michael P , Messina, Steven A. , Mark, Ian , Madhavan, Ajay A

The Neuroradiology Journal | December 26, 2023 | Volume: 37 | Issue: 6 | Pages: 761-763

10.1177/19714009231224413 | PMID 38146822 Get It

CT myelography has been traditionally used to evaluate post-operative paraspinal fluid collections to discern CSF leaking into a pseudomeningocele versus a contained seroma. Rather than performing a lumbar puncture and injecting intrathecal contrast for myelography, we present the first report of direct contrast injection into a post-operative paraspinal pseudomeningocele for CSF leak confirmation and localization. This is a simple procedure that has several advantages over a conventional CT myelogram for the evaluation of post-operative paraspinal fluid collections.
Postoperative Care of Zenker Diverticula: Contemporary Perspective from the Prospective OUtcomes Cricopharyngeaus Hypertonicity (POUCH) Collaborative
McKeon, Mallory , McCoy, Nicole, Johnson, Christopher , Allen, Jacqui , Altaye, Mekibib , Bayan, Semirra L. , Belafsky, Peter C. , deSilva, Brad W. , Dion, Gregory R. , Ekbom, Dale C. , Friedman, Aaron D. , Fritz, Mark A. , Kasperbauer, Jan L. , Kim, Brandon , Kuhn, Maggie A. , Madden, Lyndsay L. , Matrka, Laura , Mayerhoff, Ross , Piraka, Cyrus , Rosen, Clark A. , Wahab, Shaun A. , Wilson, Keith , Wright, Carter , Young, VyVy N. , Postma, Gregory N. , Howell, Rebecca J. , Bayan, Semirra, Belafsky, Peter , deSilva, Brad , Dion, Greg , Ekbom, Dale , Friedman, Aaron D , Fritz, Mark , Giliberto, John Paul , Kasperbauer, Jan , Krekeler, Brittany N , Kuhn, Maggie , Ma, Yue , Matrka, Laura , Mayerhoff, Ross , Rosen, Clark , Tabangin, Meredith , Young, Vyvy , Howell, Rebecca , Bayan, Semirra , Amin, Milan R , Giliberto, John Paul , Guardiani, Elizabeth , Kwak, Paul E. , Tabangin, Meredith E. , Wilson, Keith, Wright, Carter

The Laryngoscope | December 26, 2023 | Volume: 134 | Issue: 6 | Pages: 2678-2683

10.1002/lary.31226 | PMID 38146791 Get It

Objectives The aim of the study was to identify trends in postoperative management of persons undergoing surgery for Zenker diverticula (ZD) by evaluating length of stay (LOS), diet on discharge, and imaging with or without surgical complication. Methods Prospectively enrolled adult patients with cricopharyngeal muscle dysfunction with diverticula undergoing surgery from August 1, 2017 to February 1, 2023 were included. Data were extracted from a multi‐institutional REDCap database, summarizing means, medians, percentages, and frequencies. Fisher's exact or chi squared analyses were utilized, as appropriate, to compare subsets of data. Descriptive analysis assessed differences in clinical course and the relationship to postoperative management. Results There were 298 patients with a mean (standard deviation) age of 71.8 (11.2) years and 60% male. Endoscopic surgery was performed in 79.5% (237/298) of patients versus 20.5% (61/298) open surgery. Sixty patients (20.1%) received postoperative imaging, with four leaks identified. Complications were identified in 9.4% of cases ( n = 29 complications in 28 patients), more commonly in open surgery. Most (81.2%) patients were discharged within 23 h. About half of patients (49%) were discharged from the hospital on a pureed/liquid diet; 36% had been advanced to a soft diet. In patients without complications, LOS was significantly longer following open cases ( p = 0.002); postoperative diet was not different between open and endoscopic ( p = 0.26). Conclusions Overall, most patients are discharged within 23 h without imaging. However, LOS was affected by surgical approach. Postoperative complications are different in endoscopic versus open surgery. Complications with either approach were associated with prolonged LOS, need for imaging, and diet restriction. Level of Evidence Level III Laryngoscope , 134:2678–2683, 2024
Outcomes of mechanical thrombectomy in M1 occlusion patients with or without hyperdense middle cerebral artery sign: A systematic review and meta-analysis
Orscelik, Atakan , Şenol, Yiğit Can , Bilgin, Cem , Bilgin, Gokce Belge , Pakkam, Madona , Brinjikji, Waleed , Kallmes, David F. , Arul, Santhosh , Orscelik, Atakan , Senol, Yigit Can , Bilgin, Cem , Kobeissi, Hassan , Ghozy, Sherief , Musmar, Basel , Zandpazandi, Sara

The Neuroradiology Journal | December 26, 2023 | Volume: 37 | Issue: 4 | Pages: 454-461

10.1177/19714009231224446 | PMID 38146685 Get It

Background The comparison of mechanical thrombectomy (MT) outcomes between patients with the hyperdense middle cerebral artery sign (HMCAS) and non-HMCAS is important to evaluate the impact of this radiological finding on treatment efficacy. This meta-analysis aimed to assess the association between HMCAS and clinical outcomes in patients undergoing thrombectomy, comparing the outcomes over non-HMCAS. Methods A systematic literature search was conducted in PubMed, Ovid Embase, Google Scholar, and Cochrane Library to identify studies on MT outcomes for M1 occlusions of HMCAS over non-HMCAS. Inclusion criteria encompassed modified Rankin Scale (mRS) score, mortality, symptomatic intracranial hemorrhage (sICH), and successful recanalization. Using R software version 4.1.2, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI). Results The meta-analysis was performed for 5 studies with 724 patients. There was no association found between presence of HMCAS and achieving mRS 0–2 (OR = 0.65, 95% CI: 0.29–1.47; p = .544). Mortality analysis also showed no significant association with presence of HMCAS (OR = 0.78, 95% CI: 0.37–1.65; p = .520). No significant difference in sICH risk (OR = 1.54, 95% CI: 0.24–9.66; p = .646) was found between groups. Recanalization analysis showed a non-significant positive association (OR = 1.23, 95% CI: 0.67–2.28; p = .501). Heterogeneity was observed in all analyses. Conclusion Our findings showed that there is no statistically significant difference in mRS scores, mortality, sICH, and recanalization success rates between the HMCAS and non-HMCAS groups.
A Cross-Sectional Study of Cognitive Function, Illness Perceptions, and Immunosuppression Medication Adherence After Heart Transplantation
Al-Saleh, Stacy , Pace, Thaddeus W. W. , Insel, Kathleen C. , Conley, Samantha

Western Journal of Nursing Research | December 26, 2023 | Volume: 46 | Issue: 3 | Pages: 164-171

10.1177/01939459231220283 | PMID 38146266 Get It

Background: There are few studies that examine relationships between cognitive function, illness perceptions, and medication adherence after heart transplantation, limiting the development of effective adherence-promoting interventions. Objective: The purpose of this study was to describe relationships between cognitive function, illness perceptions, and medication adherence among heart transplant recipients. Methods: A cross-sectional, observational design was used. Measures included the telephone-Montreal Cognitive Assessment (t-MoCA©), Patient Health Questionnaire-9, Brief Test of Adult Cognition by Telephone, Basel Assessment of Adherence to Immunosuppressive Medications Scale, and the Brief Illness Perceptions Questionnaire. Descriptive statistics, point-biserial correlations, Pearson’s correlations, and logistic regression were used to describe relationships. Results: Of the 35 participants (mean age: 61 years [SD: 10.3], 71.4% male, 71.4% white), 31.4% (n = 11) were classified as nonadherent to their immunosuppression medications. Higher immediate word recall, indicating better episodic memory (memory for autobiographical and recent events), and higher illness coherence scores were associated with not missing doses of medication. Higher t-MoCA© total scores, indicating normal cognitive function, and lower depression scores were associated with taking medications on time. More than 22% (n = 8) of participants scored less than 19 on the t-MoCA©, an indication of mild cognitive impairment. Conclusion: Cognitive impairment may be more common among heart transplant recipients than what is currently recognized, and specific domains of cognitive function were related to medication adherence after transplantation in this study. Future studies should include longitudinal evaluations of cognitive function, depression, and medication adherence. Consideration of these relationships is needed when designing adherence-promoting interventions for this population.
Fluctuating hearing loss secondary to spontaneous intracranial hypotension: A case report and review of the literature
Cahal, Michal , Ungar, Omer J. , Brinjikji, Waleed , Roth, Jonathan

Interventional Neuroradiology | December 26, 2023 | Volume: 32 | Issue: 3 | Pages: 1111-1117

10.1177/15910199231221863 | PMID 38146166 Get It

Objective Fluctuating sensorineural hearing loss (SNHL) has multiple etiologies, most commonly Ménière's disease (MD), recurrent sudden SNHL, and autoimmune inner ear disorders. Fluctuating SNHL has rarely been described as a symptom of spontaneous intracranial hypotension (SIH). Patient A 39-year-old previously healthy female presented with “Ménière's like” symptoms responsive to steroid treatment, which worsened during the day and improved in the supine position. Conservative treatment for MD consisting of low salt and caffeine diet and betahistine medication yielded no improvement. Secondary revision of brain imaging scans showed signs indicative of SIH, and a spinal cerebrospinal fluid leak was ultimately found and treated by a novel technique of transvenous fistula embolization by means of Onyx® glue, leading to gradual clinical improvement and near-complete resolution of symptoms. Conclusion SIH should be considered as part of the differential diagnosis of fluctuating SNHL. Clinical and radiological features should be known and sought. We suspect that early diagnosis and treatment can lead to cure and prevent permanent auditory damage.
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network
Zambrano, Laura D. , Newhams, Margaret M. , Fleming‐Dutra, Katherine E. , Halasa, Natasha , Wu, Michael , Orzel-Lockwood, Amber O., Kamidani, Satoshi , Pannaraj, Pia S. , Chiotos, Kathleen , Cameron, Melissa A. , Schuster, Jennifer E. , Crandall, Hillary , Kong, Michele , Nofziger, Ryan A. , Staat, Mary Allen , Bhumbra, Samina S. , Irby, Katherine , Boom, Julie A. , Hume, Janet R. , Gertz, Shira J. , Maamari, Mia , Bowens, Cindy , Levy, Emily R. , Bradford, Tamara T. , Walker, Tracie C. , Mack, Elizabeth , Guzman‐Cottrill, Judith A. , Zinter, Matt S. , Bline, Katherine , Randolph, Adrienne G. , Investigators, for the Overcoming COVID-19, Levy, Emily R. , Malloch, Lacy , Simeone, Regina M , Fleming-Dutra, Katherine E , Halasa, Natasha , Wu, Michael , Kamidani, Satoshi , Pannaraj, Pia S , Chiotos, Kathleen , Cameron, Melissa A , Maddux, Aline B , Crandall, Hillary , Kong, Michele , Nofziger, Ryan A , Staat, Mary A , Bhumbra, Samina S , Irby, Katherine , Sahni, Leila C , Hume, Janet R , Gertz, Shira J , Maamari, Mia , Bowens, Cindy , Bradford, Tamara T , Walker, Tracie C , Schwartz, Stephanie P , Mack, Elizabeth H , Guzman-Cottrill, Judith A , Hobbs, Charlotte V , Cvijanovich, Natalie Z , Bline, Katherine E , Hymes, Saul R , Campbell, Angela P , Randolph, Adrienne G , Levy, Emily R , Zambrano, Laura D , Simeone, Regina M. , Maddux, Aline B. , Schwartz, Stephanie P. , Hobbs, Charlotte V. , Hymes, Saul , Investigators, for the Overcoming COVID-19

Pediatric Infectious Disease Journal | December 25, 2023 | Volume: 43 | Issue: 3 | Pages: 242-249

10.1097/inf.0000000000004225 | PMID 38145397 Get It

Background and objectives: In June 2022, the mRNA COVID-19 vaccination was recommended for young children. We examined clinical characteristics and factors associated with vaccination status among vaccine-eligible young children hospitalized for acute COVID-19. Methods: We enrolled inpatients 8 months to <5 years of age with acute community-acquired COVID-19 across 28 US pediatric hospitals from September 20, 2022 to May 31, 2023. We assessed demographic and clinical factors, including the highest level of respiratory support, and vaccination status defined as unvaccinated, incomplete, or complete primary series [at least 2 (Moderna) or 3 (Pfizer-BioNTech) mRNA vaccine doses ≥14 days before hospitalization]. Results: Among 597 children, 174 (29.1%) patients were admitted to the intensive care unit and 75 (12.6%) had a life-threatening illness, including 51 (8.5%) requiring invasive mechanical ventilation. Children with underlying respiratory and neurologic/neuromuscular conditions more frequently received higher respiratory support. Only 4.5% of children hospitalized for COVID-19 (n = 27) had completed their primary COVID-19 vaccination series and 7.0% (n = 42) of children initiated but did not complete their primary series. Among 528 unvaccinated children, nearly half (n = 251) were previously healthy, 3 of them required extracorporeal membrane oxygenation for acute COVID-19 and 1 died. Conclusions: Most young children hospitalized for acute COVID-19, including most children admitted to the intensive care unit and with life-threatening illness, had not initiated COVID-19 vaccination despite being eligible. Nearly half of these children had no underlying conditions. Of the small percentage of children who initiated a COVID-19 primary series, most had not completed it before hospitalization.
Relationship between Arterial Transit Time and Framingham Risk Score in the U.S. POINTER lifestyle intervention trial
Hong, Sarah Y., Kim, Dong‐Hoon , Borowski, Bret, Gordineer, Leslie, Woolard, Nancy , Lovato, Laura, Masdeu, Joseph C. , Oh, Hwamee , Aggarwal, Neelum T. , Carrillo, Marı́a C., Snyder, Heather M. , Whitmer, Rachel A. , Landau, Susan, Group, U.S. POINTER Study, Jung, Youngkyoo , Vemuri, Prashanthi , Jack, Clifford R. , Koeppe, Robert A. , Lockhart, Samuel N. , Harrison, Theresa M. , Espeland, Mark Andrew , Harvey, Danielle , Toga, Arthur W. , Masdeu, Joseph C , Gitelman, Darren R. , Baker, Laura D. , DeCarli, Charles , Group, U.S. POINTER Study

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S24 | Pages: No page available

10.1002/alz.083207 Get It

AbstractBackgroundThe U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a two‐year randomized controlled trial designed to evaluate the effects of lifestyle interventions on older adults aged 60‐79 years. The POINTER Imaging ancillary study employs arterial spin labeling (ASL) magnetic resonance imaging (MRI) with two inversion times, enabling the mapping of arterial transit time (ATT) and the investigation of its relationship with dementia risk factors. This study examines the effect of the Framingham Risk Score (FRS) on ATT, which provides hemodynamic information on the cerebral vasculature.MethodA subset of POINTER Imaging participants (n = 134; F/M = 81/53; age = 68.1±5.1; FRS = 11.3±10.4) from two imaging sites underwent two ASL MRI scans during the baseline session. Two 3D Pulsed ASL scans were obtained with TI1 of 790ms and TI2 values of 2000ms or 2750ms, providing delay times (between labeling and imaging) of 1210ms or 1960ms. ATT, the time required for blood to travel from the neck to the tissue, was estimated in the range of 1210ms and 1960ms using a kinetic model (Figure 1). ATT maps were normalized to a standard space, and a voxel‐wise linear regression (ATT∼age+sex+log(FRS)) was performed on ATT maps in gray matter to assess the effect of FRS on ATT. To control false positives, clusters smaller than 1.4ml were removed based on a simulation with α = 0.05.ResultFigure 2 depicts three clusters found in the occipital, precuneus and frontal gray matter regions, all of which demonstrate a positive relationship between ATT and log(FRS). Participants with higher FRS exhibit prolonged mean ATT values in the clusters as shown in Figure 3. After stratifying into sex groups, both groups show the same direction.ConclusionAlthough the detectable range of ATT with two ASL scans was limited, the analysis suggests that an increased risk of cardiovascular disease, as quantified by the Framingham Risk Score, can serve as an indicator of potential cerebrovascular disease leading to prolonged ATT, which is associated with arterial stiffness, and vascular resistance. The clusters demonstrating the association between FRS and ATT are the brain regions that may have heightened vulnerability to vascular risk factors, according to previous studies.
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early‐ Onset Alzheimer’s Disease Study (LEADS) Cohort
Wonderlin, Ryan J., Hammers, Dustin B. , Garcia, Alex Pena, Eloyan, Ani , Taurone, Alexander, Thangarajah, Maryanne, Gao, Sujuan , Kirby, Kala, Aisen, Paul , Griffin, Percy , Iaccarino, Leo, Kramer, Joel H. , Soleimani‐Meigooni, David N. , Rumbaugh, Malia, Touroutoglou, Alexandra , Duara, Ranjan , Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan C., Rogalskı, Emily , Salloway, Stephen , Sha, Sharon, Dickerson, Brad C., Apostolova, Liana G. , Polsinelli, Angelina J. , Hammers, Dustin B , Beckett, Laurel , Wang, Sophia , Logan, Paige E. , Dage, Jeffrey L. , Foroud, Tatiana , Koeppe, Robert A. , Kukull, Walter A. , Joie, Renaud La , Mundada, Nidhi S. , Murray, Melissa E. , Nudelman, Kelly , Toga, Arthur W. , Vemuri, Prashanthi , Atri, Alireza , Day, Gregory S. , Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Musiek, Erik , Sha, Sharon J. , Turner, Raymond Scott , Wingo, Thomas S , Wolk, David A. , Womack, Kyle , Carrillo, María C. , Rabinovici, Gil D.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S24 | Pages: No page available

10.1002/alz.083140 Get It

AbstractBackgroundWe examined neuropsychiatric symptoms (NPS) and psychotropic medication use at the midway point of data collection of the Longitudinal Early‐onset Alzheimer’s Disease Study (LEADS). We compared amyloid‐positive early‐onset Alzheimer’s disease (EOAD) participants and amyloid‐negative early‐onset non‐Alzheimer’s disease [EOnonAD]) participants across NPS domains and psychotropic medication categories.Method282 participants enrolled in LEADS were compared across diagnostic groups – amyloid‐positive EOAD (n = 212) and amyloid‐negative EOnonAD (n = 70). All participants were between ages 40 and 64 at baseline. NPS were measured with the Neuropsychiatric Inventory – Questionnaire (NPI‐Q) and Geriatric Depression Scale – Short Form (GDS‐SF). Medications were categorized into psychotropic category (e.g., antidepressants, antipsychotics, benzodiazepines). Groups were compared on NPI‐Q using binary logistic regression adjusting for sex and disease severity, on GDS‐SF using linear regression adjusting for sex and disease severity, and on psychotropic medication use using Chi square or Fisher’s exact test.ResultDemographic data are presented in Table 1. Average total NPI‐Q score was higher in EOnonAD than EOAD (p = .002, ŋp 2 = .03). Regardless of diagnostic group, informants endorsed Affective behaviors most frequently (76.2%). EOAD informants endorsed fewer Distress‐Tension behaviors (p = .02, OR = .498) and Impulse Control behaviors (p = .01, OR = .438). EOAD informants also endorsed apathy (p < .001, OR = .316), irritability (p = .02, OR = .498), and disinhibition (p = .04, OR = .476) at lower frequency than EOnonAD. GDS‐SF showed that the EOnonAD participants self‐reported more symptoms of depression than the EOAD group (p = .002, ŋp 2 = .03). (Table 2A). A minority of participants, regardless of diagnostic group, reported psychotropic medication use (35%). There was higher use in EOnonAD (38%) than EOAD (24%) (p = .03, Cohen W = .14) (Table 2B).ConclusionNPS burden and psychotropic medication use were higher in EOnonAD than EOAD participants, despite EOnonAD being less severely impaired. LEADS continues to collect data. Future studies will examine etiologies that may be larger drivers of NPS than AD neuropathology, mediators (e.g., race, ethnicity) in the association between NPS and diagnostic group classication, compare NPS in EOAD vs. LOAD, and examine longitudinal changes in neuropsychiatric profiles.
Comparison of self‐similarity measures in FDG‐PET images and association with disease progression risk
Dicks, Ellen , Barnard, Leland R , Graff‐Radford, Jonathan , Gunter, Jeffrey L. , Lee, Jeyeon , Lowe, Val J. , Petersen, Ronald C. , Boeve, Bradley F. , Botha, Hugo , Corriveau‐Lecavalier, Nick , Knopman, David S. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Jones, David T.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S24 | Pages: No page available

10.1002/alz.083097 Get It

AbstractBackgroundDecreased image self‐similarity of repeated FDG‐PET scans has been suggested to indicate increased risk for disease progression. Here, we compared several self‐similarity measures based on conventionally used voxel‐ and ROI‐based approaches and those based on patterns of cortical metabolism.MethodFrom the MCSA/ADRC, we included 376 cognitively unimpaired (CU) individuals and those with a clinical diagnosis of MCI (n = 55) or AD (n = 20) who had two FDG‐PET images within 2‐3 years and clinical follow‐up available. We compared image self‐similarity for three approaches: voxel, ROI and “eigenbrain” (Fig.1). For the voxel approach, FDG‐PET images were normalized to template space, grey matter masked, and intensity normalized to the pons to create standard uptake value ratios (SUVR) for each voxel. From these images, mean SUVR were extracted for 122 ROIs (MCALT‐ADIR122) for the ROI approach. For the “eigenbrain” approach, the SUVR images were transformed to a latent space embedding composed of 253 components (“eigenbrains”) and reflecting metabolism patterns, that was generated in an independent sample of 7008 FDG‐PET images. For each approach, image self‐similarity between baseline and follow‐up values (voxel, ROI or eigenbrain) was determined using three metrics (Pearson correlation, cosine, Euclidean distance). We computed AUC to determine which approach and metric would best discriminate between groups. We used Cox regression analyses to assess whether the metrics could predict disease progression.ResultComparing each distance metric across approaches, AUC was highest in differentiating clinical diagnoses using self‐similarity measures based on eigenbrains, then voxels, then ROIs (e.g., Euclidean distance CU vs AD AUC eigenbrain: 0.86, voxel: 0.75, ROI: 0.71; Fig.1). Across all approaches, Euclidean distance always discriminated best between classes. Eigenbrain‐based Euclidean distance was associated with risk for progression to MCI in CU (HR [95%CI]: 1.25 [1.05, 1.49]), and eigenbrain‐based cosine and Euclidean distances were associated with risk for progression to AD in MCI (1.61 [1.1, 2.34] and 1.53 [1.01, 2.31], respectively), while we found no associations for voxel‐ or ROI‐based distance measures.ConclusionEigenbrain‐based measures outperformed other, more conventional approaches in discriminating clinical diagnoses, and were associated with risk for disease progression. Our results suggest that decreased self‐similarity in metabolism patterns informs on disease stage and prognosis.